Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

J&J’s Third-Quarter Profit Beats Estimates on Drug Sales
Bloomberg
Tuesday, October 16, 2012 - 9:25am
tags:
earnings, JNJ
AstraZeneca Expands R&D in China to Boost Drug Discovery
Bloomberg
Monday, October 15, 2012 - 11:44am
tags:
R&D, China, AstraZeneca
Prima BioMed announces interim data from CAN-003 trial
Yahoo/Fly on the Wall
Monday, October 15, 2012 - 11:43am
tags:
Prima BioMed, CAN-003, ovarian cancer
Kidney Week Should Prove Beneficial For Questcor's Acthar
Seeking Alpha
Monday, October 15, 2012 - 11:42am
tags:
Questcor, Acthar
Dendreon and Celgene Cancer Treatment Catalysts Face Rocky Road
Wall St. Cheat Sheet
Monday, October 15, 2012 - 11:41am
tags:
Celgene, Dendron, Provenge, prostate cancer
Merck gets rights to HCMV drug from Bayer spin-off AiCuris
Pharma Times, UK
Monday, October 15, 2012 - 11:40am
tags:
Merck, Bayer, AiCuris, HCMV, letermovir
Lilly's ImClone Purchase Pays Off
Forbes
Monday, October 15, 2012 - 11:38am
tags:
Eli Lilly, ImClone, ramucirumab
Bristol-Myers Trails U.S. Rivals as Promising Drugs Fade
Bloomberg
Monday, October 15, 2012 - 11:38am
tags:
Bristol-Myers Squibb
Abbott Hep C Therapy Achieves Almost-Perfect Cure Rate
TheStreet.com
Monday, October 15, 2012 - 11:37am
tags:
Abbott Labs, hepatitis C, ABT-450, ABT-267, ABT-333, Gilead
FDA panel says lomitapide data supports 'appropriate use'
Yahoo/Fly on the Wall
Monday, October 15, 2012 - 11:11am
tags:
FDA, lomitapide, advisory panels, HoFH, Homozygous Familial Hypercholesterolemia, Aegerion
Forbes Earnings Preview: Abbott Laboratories
Forbes
Monday, October 15, 2012 - 10:43am
tags:
earnings, Abbott Labs
Biotech Investors: Are We Blinded By Clinical Trials?
Seeking Alpha
Monday, October 15, 2012 - 10:42am
tags:
clinical trials, Abbott Labs, Aeterna Zentaris, Dendreon, Keryx
Lilly's gastric cancer drug meets late-stage goal
Reuters
Monday, October 15, 2012 - 10:41am
tags:
gastric cancer, Eli Lilly, ramucirumab
Kythera Biopharmaceuticals: Successful Offering Of This One-Drug Company Backed By Bayer
Seeking Alpha
Monday, October 15, 2012 - 10:37am
tags:
Kythera, IPOs, facial aesthetics
Is Wall Street Too Eager To Get Excited About Eli Lilly's Alzheimer's Drug?
Forbes
Monday, October 15, 2012 - 10:36am
tags:
Eli Lilly, Alzheimer's disease, solanezumab
Aegerion Vs. Isis: Which One Is The Buy?
Seeking Alpha
Monday, October 15, 2012 - 10:35am
tags:
Isis Pharmaceuticals, Aegerion, FDA, advisory panels, mipomersen, lomitapide
Will Expedited Approval Spell Fat Profits for Drug Makers?
Motley Fool
Sunday, October 14, 2012 - 11:22am
tags:
Is This Giant Drug Stock a Buy, Hold or Sell Today?
Wall St Cheat Street
Sunday, October 14, 2012 - 11:21am
tags:
Merck
Breckenridge announces agreement with Marksans Pharma, Ltd. to market Gabapentin Capsules By Breckenridge Pharmaceutical, Inc.
Sacramento Bee, CA
Sunday, October 14, 2012 - 11:20am
tags:
gabapentin, Breckenridge, Marksans Pharma
5 Top Pharmaceuticals Paying Substantial Dividends
Seeking Alpha
Sunday, October 14, 2012 - 11:19am
tags:
Bristol-Myers Squibb, JNJ, Eli Lilly, Pfizer, Merck

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.